Vickie S. Reed - 24 May 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Role
Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 16:19:03 UTC
Previous filing
28 Apr 2022
Next filing
11 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Stock Appreciation Right Award $0 +50,000 $0.000000 50,000 24 May 2022 Common Stock 50,000 $0.4100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Appreciation Right can only be settled in cash.
F2 The Stock Appreciation Right ("SAR") will vest with respect to 1/6 of the shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter with respect to 1/36 of the shares on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant.

Remarks:

* Exhibit 24 - Power of Attorney.